US 11,998,688 B2
Nasal medication or drug delivery devices and methods
Kevin Simpson, Austin, TX (US); Nicholas Norman, Charlotte, NC (US); and Alan Snyder, Charleston, SC (US)
Assigned to Indev, LLC, Austin, TX (US)
Filed by INdev, LLC, Austin, TX (US)
Filed on Jun. 24, 2020, as Appl. No. 16/911,096.
Claims priority of provisional application 62/865,783, filed on Jun. 24, 2019.
Prior Publication US 2020/0398005 A1, Dec. 24, 2020
Int. Cl. A61M 15/08 (2006.01); A61M 11/00 (2006.01); A61M 11/02 (2006.01); A61M 15/00 (2006.01)
CPC A61M 15/08 (2013.01) [A61M 11/002 (2014.02); A61M 11/02 (2013.01); A61M 15/0013 (2014.02); A61M 15/0025 (2014.02); A61M 15/0035 (2014.02); A61M 15/0066 (2014.02); A61M 15/009 (2013.01); A61M 2205/273 (2013.01); A61M 2210/0618 (2013.01)] 12 Claims
OG exemplary drawing
 
1. A nasal delivery device for delivering a medication or drug to a nasal passageway in a metered amount, comprising: a connection adapter having a receiving portion comprising a puncturing member; one or more sealing members presented on the connection adapter; a first chamber portion, comprising a first chamber, presenting a metered amount indicator and being fluidly coupled to the connection adapter; and a second chamber portion, comprising a second chamber, having a fluid atomizing tip, the second chamber fluidly coupled to the first chamber, and the second chamber allowing for free movement and positioning relative to the first chamber to a set position along the metered amount indicator to thereby establish a selected metered dose volume jointly defined by the first chamber and the second chamber; while maintaining a liquid seal therebetween.